# Seroquel Long-Term NIS for Schizophrenia Patients

> **NCT00523783** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1000 (estimated)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00523783
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2007-11
- **Final completion:** 2008-05
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2008-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00523783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00523783, "Seroquel Long-Term NIS for Schizophrenia Patients". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00523783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*